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Abstract
Background: Small molecule inhibitors of RNA virus replication are potent antiviral drugs and useful to dissect selected
steps in the replication process. To identify antiviral compounds against Tomato bushy stunt virus (TBSV), a model positive
stranded RNA virus, we tested acridine derivatives, such as chlorpromazine (CPZ) and quinacrine (QC), which are active
against prion-based diseases.
Methodology/Principal Findings: Here, we report that CPZ and QC compounds inhibited TBSV RNA accumulation in plants
and in protoplasts. In vitro assays revealed that the inhibitory effects of these compounds were manifested at different steps
of TBSV replication. QC was shown to have an effect on multiple steps, including: (i) inhibition of the selective binding of the
p33 replication protein to the viral RNA template, which is required for recruitment of viral RNA for replication; (ii) reduction
of minus-strand synthesis by the tombusvirus replicase; and (iii) inhibition of translation of the uncapped TBSV genomic
RNA. In contrast, CPZ was shown to inhibit the in vitro assembly of the TBSV replicase, likely due to binding of CPZ to
intracellular membranes, which are important for RNA virus replication.
Conclusion/Significance: Since we found that CPZ was also an effective inhibitor of other plant viruses, including Tobacco
mosaic virus and Turnip crinkle virus, it seems likely that CPZ has a broad range of antiviral activity. Thus, these inhibitors
constitute effective tools to study similarities in replication strategies of various RNA viruses.
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Introduction
Viruses, including plant viruses, cause many diseases that lead to
significant economic losses. Therefore, it is important to develop
antiviral strategies to efficiently combat viral infections. One
intriguing approach is the use of small molecule inhibitors of viral
infections as demonstrated by the use of ribavirin against hepatitis
C virus (HCV), respiratory syncytial virus and treatment of Lassa
fever as well as amantadine and rimantadine M2 channel
inhibitors and zanamivir and oseltamivir neuraminidase inhibitors
against influenza virus [1,2,3]. Additional 40 antiviral drugs have
been approved for treatment of human immunodeficiency virus
and herpesviruses [2]. To find additional inhibitors of viral
infections, researchers screened small molecule libraries that
identified a few more potent antiviral chemicals [4,5,6,7,8,9].
In spite of the above progress with small molecule inhibitors of
human and animal viruses, identification of small molecule
inhibitors to combat plant virus infections is much less advanced.
Therefore, we have chosen a simple model virus, Tomato bushy stunt
virus (TBSV), to test small molecule inhibitors. TBSV, a small
(+)RNA virus of plants, has emerged as a highly suitable model virus
for studying viral RNA replication and recombination [10]. The
genomic (+)RNA of TBSV codes for p33 and p92pol replication
proteins [10]. p33 is an essential replication co-factor performing
recruitment of the viral RNA template into replication [11,12,13],
and in the assembly of the viral replicase [14]. The p92pol is the
RNA-dependent RNA polymerase (RdRp) [15,16,17]. Both
replication proteins are integral part of the tombusvirus replicase
complex, which also contains host proteins [18,19]. Several of these
host factors have been identified via proteomics approaches
[19,20,21]. The list includes the heat shock protein 70 chaperones
(Ssa1/2p in yeast), glyceraldehyde-3-phosphate dehydrogenase
(GAPDH, encoded by TDH2 and TDH3 in yeast), pyruvate
decarboxylase (Pdc1p), Cdc34p ubiquitin conjugating enzyme and
eukaryotic translation elongation factor 1A (eEF1A) [19,20,21].
These host factors provide various functions, such as facilitating the
assembly of the viral replicase complex and promoting asymmet-
rical viral RNA synthesis [22,23,24,25].
One of the major advantages of tombusviruses is the
development of yeast as a model host for virus - host interactions,
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allowing the utilization of powerful genomics and proteomics tools
developed for yeast [16,24]. Systematic genome-wide screens
covering 95% of yeast genes have led to the identification of over
100 host factors affecting TBSV RNA replication [20,21,26,27].
One of the surprising findings from these genome-wide screens is
the observation that TBSV co-opt some host factors that also affect
prion propagation, such as protein chaperones and ribosomal
proteins [20,21,26,27].
Based on the above observation, we have tested in this paper if
inhibitors of prion propagation active against both yeast and
mammalian prions [28] could also reduce TBSV replication. We
found that two acridine derivatives, namely chlorpromazine (CPZ)
and quinacrine (QC), inhibited TBSV RNA accumulation
significantly in single plant cells. Besides their anti-prion effect,
QC and CPZ have been used in humans for many years,
respectively, as antimalarial and antipsychotic drugs [29,30,31].
Detailed studies on the mechanism of inhibition revealed that
inhibition by CPZ and QC was due to effects of these compounds
on the following steps: (i) inhibition of the assembly of the viral
replicase complex (for CPZ), suppression of production of viral
replication proteins during translation (for QC); (ii) inhibition of
RNA–viral protein interaction during RNA recruitment for
replication (for QC); and reducing minus-strand synthesis (for
QC). Altogether, these acridine derivatives could be useful
antiviral compounds against selected plant viruses.
Results
Acridine Derivatives Chlorpromazine and Quinacrine
Inhibit TBSV RNA Accumulation in N. Benthamiana
Protoplasts
Wehave tested two acridine derivatives chlorpromazine (CPZ) and
quinacrine (QC), which are known anti-prion molecules active
against both yeast [28] and mammalian prions [29,30,31] for their
effects on TBSV replication in plant protoplasts. The TBSV genomic
(g)RNA was introduced via electroporation into Nicotiana benthamiana
protoplasts, whereas CPZ and QC were added to the culture media
either prior to electroporation or after electroporation (Fig. 1). We
have applied the chemicals in various concentrations to test for their
optimal antiviral effects as well as for possible cytotoxic effects on the
N. benthamiana cells (not shown). We found that both CPZ and QC
inhibited TBSV accumulation by ,70 and 50%, respectively, when
applied prior to electroporation (Fig. 1, lanes 9 and 13). CPZ was also
effective in reducing TBSV RNA accumulation by 60% in
protoplasts when applied after electroporation, albeit in higher
concentration than used for pre-electroporation (Fig. 1, lanes 10
versus 13). QC was not able to reduce TBSV accumulation as
efficiently when applied after electroporation (Fig. 1, lane 6).
Altogether, these in vivo experiments have established that both
CPZ and QC have anti-TBSV effects in single plant cells.
CPZ and QC Inhibit TBSV RNA Replication In Vitro
To define the mode of action for these acridine derivatives
leading to inhibition of TBSV RNA accumulation, we took
advantage of efficient in vitro replication assays developed for
tombusviruses. First, we used an in vitro replicase assembly assay
that includes purified recombinant TBSV p33 and p92pol
replication proteins and a yeast cell-free extract [23]. This cell-
free system can be programmed with plus-stranded (+)TBSV
replicon (rep)RNA, which leads to the assembly of the TBSV
replicase on the membranes. The in vitro assembled replicase is
capable of supporting complete cycle of TBSV replication leading
to the production of (+)repRNA progeny [23,32]. Testing the
effect of CPZ and QC revealed 90–95% inhibition of TBSV
replication when the chemicals were applied at an early time point
of the assay (Fig. 2A, lanes 2–4 and 10–12). In the in vitro replicase
assembly assay, the first 40 min consist of recruitment of the
repRNA, the viral replication proteins and host proteins, such as
Hsp70 to the membrane [23,32], followed by the assembly of the
membrane-bound replicase complex, whereas viral RNA synthesis
occurs after ,20–40 min of incubation until ,3 hours. These
experiments revealed that both CPZ and QC inhibited TBSV
repRNA replication when added at the beginning of incubation (0
time point) (Fig. 2A, lanes 4 and 12), while they were not as
Figure 1. Inhibition of TBSV gRNA accumulation in N. benthamiana protoplasts by treatment with CPZ or QC. Northern blot analysis
with a 39 end specific probe was used to detect the accumulation levels of TBSV gRNA and subgenomic (sg)RNAs. The N. benthamiana protoplasts
were treated with the shown concentrations of CPZ and QC either before or after electroporation. The samples were harvested 40 hours after
electroporation. The ethidium-bromide stained gel at the bottom shows the ribosomal (r)RNA levels as loading controls. As a control, DMSO, the
solvent for CPZ and QC, concentrations were the following: 0.04%, lanes 2,6; 0.005%, lanes 3,7, 12; 0.01%, lanes 4,8,13; and 0.02%, lanes 5 and 9. Note
that the gRNA can reach rRNA levels in N. benthamiana protoplasts. The survival of the plant cells (after electroporation and treatment) was checked
by measuring rRNA levels in total RNA extracts.
doi:10.1371/journal.pone.0007376.g001
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effective at the 60-min time point (lanes 1 and 9). This suggests
that CPZ and QC likely inhibit the early steps in virus replication,
possibly including the recruitment of the viral RNA or the
assembly of the functional replicase complex in the membrane,
while they could only partially inhibit viral RNA synthesis in vitro.
CPZ Inhibits the Formation of the TBSV Replicase
Complex In Vitro
The viral replication proteins have to be associated with
membranes for the functional assembly of the tombusvirus
replicase [12,32]. CPZ is known to bind to phospholipids and
modify the features of membranes [33]. Therefore, we have tested
if treatment of the membranes by CPZ could affect the subsequent
assembly of the TBSV replicase. First, we pretreated the
membrane fraction of the yeast cell extract for 15 min with either
CPZ, QC or DMSO as a control, and then we washed the
membrane fraction with buffer A to remove the chemicals not
bound to membrane lipids. Second, to the pre-treated membrane
fraction, we added the TBSV (+)repRNA and the purified
recombinant p33 and p92pol proteins in combination with the
Figure 2. Inhibition of in vitro replication of TBSV repRNA in a cell-free extract by CPZ and QC. (A) The first in vitro replication assay
contained a yeast cell-free extract, purified recombinant p33 and p92pol, a mixture of radiolabeled and unlabeled nucleotides and was programmed
with TBSV DI-72 (+)repRNA. CPZ, QC and DMSO were added to the assay at 0, 20, 40 or 60 min after the start of the assay, which lasted for 3 hours.
The newly made repRNA products were analyzed on denaturing PAGE. Note that the repRNA goes through a full replication cycle in this replication
assay, producing mostly (+)-stranded progeny RNAs. (B) The second in vitro replication assay was similar to that described in panel A, except that the
membrane fraction of the yeast cell-free extract was treated with CPZ, QC or DMSO first, followed by a washing step to remove the unbound
compounds. This was followed by the addition of the soluble fraction of the yeast cell-free extract, purified recombinant p33 and p92pol, a mixture of
radiolabeled and unlabeled nucleotides and was programmed with TBSV DI-72 (+)repRNA. DMSO concentrations were the following: 0.05%, lanes 1,
2, 3, 7, 9, 10 and 0.02% in lanes 4, 5, 6, 8, 11, and 12. The experiments were done in duplicates and the right panel shows reproducibility. The data
show the averages and standard deviations including both sets. (C) The third in vitro replication assay contained a partially purified tombusvirus
replicase preparation, a mixture of radiolabeled and unlabeled nucleotides and was programmed with TBSV DI-72 (+)repRNA. Note that the repRNA
can only produce the complementary (minus-stranded RNA) product in this assay. (D) The fourth in vitro replication assay was similar to that
described in panel C, except (2)-stranded repRNA was used to generate (+)-stranded RNA products. Note that the solubilized/purified tombusvirus
replicase also generates internally initiated (marked as ‘‘ii’’) products on (2)RNA template.
doi:10.1371/journal.pone.0007376.g002
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soluble fraction of the yeast extract. Under these conditions, the
TBSV replicase can be successfully assembled in vitro and
accordingly, replication of TBSV (+)repRNA was detected in the
in vitro replication assay in the presence of the control DMSO
(Fig. 2B, lanes 3–4 and 7–8). Interestingly, pre-treatment of the
membrane fraction with CPZ led to 3-fold decrease in the TBSV
replicase activity in vitro (Fig. 2B, lanes 1–2 and 9–10), whereas
pre-treatment with QC had less than 20% inhibitory effect (lanes
5–6 and 11–12). These results demonstrated that pre-treatment of
the membrane with CPZ inhibits the subsequent assembly of the
TBSV replicase complex.
QC Inhibits Minus-Strand Synthesis by the Tombusvirus
Replicase
To test if CPZ and QC can inhibit minus- or plus-strand
synthesis by the tombusvirus replicase, we also used an in vitro
replicase assay based on solubilized and partially purified
tombusvirus replicase from infected plants [34]. This solubilized
tombusvirus replicase can use exogenous (added) template for
complementary RNA synthesis only [34,35]. When programmed
with (+)repRNA template, the activity of the solubilized and
partially purified tombusvirus replicase was reduced to 23% by
QC treatment (Fig. 2C, lanes 3, 8, 9), whereas CPZ had only
minor effect (lanes 2, 4, 5) when compared with the DMSO
treated sample (lanes 1, 6, 7). On the other hand, neither
compounds inhibited the activity of the solubilized and partially
purified tombusvirus replicase programmed with a (2)repRNA
template (Fig. 2D, lanes 2–3 and 5–6). Based on these data, we
suggest that QC can selectively inhibit minus-strand synthesis,
whereas the plus-strand synthesis is unaffected. On the other hand,
CPZ does not seem to inhibit (2) or (+)-strand synthesis
significantly by the tombusvirus replicase in vitro.
QC Inhibits the Binding of p33 Replication Protein to the
Viral (+)RNA
Previous works defined that binding of p33 replication protein
to an internal recognition element, termed p33RE, which consist
of a CNC mismatch within an internal stem-loop structure RII(+)-
SL, is absolutely essential for TBSV replication in plants, plant
protoplasts, in yeast cells and in the authentic in vitro TBSV
replication system [11,13,32]. The binding of p33 to RII(+)-SL is
required for template selection, the recruitment of the viral RNA
for replication and for assembly of the active replicase complex.
To test if binding of p33 to RII(+)-SL is affected by CPZ and QC,
we performed in vitro gel-shift experiments with purified
components. This assay is suitable to obtain information on
binding of p33 to the viral RNA, which is relevant for in vivo
TBSV RNA recruitment activity of p33 [13]. We found that QC
strongly inhibited p33-RII(+)-SL interaction in vitro (Fig. 3B, lanes
1–4 versus 5–8), whereas the effect of CPZ was less pronounced at
high p33 concentrations (Fig. 3A, lanes 3–4). Altogether, these in
vitro binding experiments suggest that QC can strongly interfere
with binding of p33 to the TBSV (+)RNA, thus inhibiting the
recruitment of (+)repRNA into replication, whereas the effect of
CPZ on the interaction might only be effective at lower p33
concentrations (e.g., in the beginning of infection).
QC Inhibits Translation of Uncapped and
Nonpolyadenylated TBSV RNA
Another potential target for CPZ and QC is inhibition of
translation of viral (+)RNA to produce p33 and p92pol that would
lead to reduced amount of replicase complex and low level of
replication. To test this possibility, we used the in vitro wheat germ
translation assay that can be programmed with added RNA
templates. When capped and polyadenylated mRNA for p33
(similar to that expressed in yeast from plasmid to support TBSV
replication) [16] was used, then we did not observe any major
inhibitory effect by CPZ and QC (Fig. 4A, lanes 3–6). In contrast,
in vitro translation of uncapped and nonpolyadenylated TBSV
RNA, which is the common form of TBSV RNA replicating in N.
benthamiana protoplasts (Fig. 1A), was inhibited by QC at 20 mM
concentration resulting in ,15% p33 when compared with the
DMSO-treated control (Fig. 4B, lanes 4 versus 1), whereas CPZ
did not have significant inhibitory effect (lanes 2–3). Thus, QC
seems to selectively inhibit the translation of uncapped and
nonpolyadenylated TBSV gRNA.
CPZ and QC Inhibit TBSV RNA Accumulation in N.
Benthamiana Plants
Based on the above in vitro experiments, CPZ and QC might
inhibit TBSV replication directly, encouraging us to further test
the antiviral activities of these compounds in plant leaves as well.
Our preliminary experiments have indicated that both compounds
were needed at higher concentrations for treatment of plant leaves
(not shown) than for the protoplasts experiments (Fig. 1).
Infiltration of leaves with 600 mM CPZ solution 30 min prior to
inoculation of the same leaves with TBSV virion preparation
Figure 3. Inhibition of in vitro binding of p33 replication co-
factor to TBSV (+)RNA by QC and CPZ. (A) The in vitro band-shift
assay included the radiolabeled RII(+)-SL sequence, which is present
within the p92 ORF in the TBSV gRNA, and 1.0, 0.4, 0.2 or 0.1 mg of
purified recombinant p33C as well as CPZ (50 mM) or DMSO (0.01% final
concentration). p33C is a soluble, N-terminally truncated version of p33
(contains the RNA-binding domain as well) fused to MBP. Purified
recombinant MBP was used as a negative control. The binding was
analyzed in 5% nondenaturing PAGE. The bound RNA in the DMSO
control (lane 8) was chosen as 100%. Quantitation showed that the free
RNA negatively correlated with the bound RNA. (B) Similar in vitro
band-shift assay using QC (20 mM final concentration) as an inhibitor.
doi:10.1371/journal.pone.0007376.g003
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resulted in 99% inhibition of TBSV RNA accumulation at 4 dpi
(Fig. 5A). Interestingly, the CPZ treatment also inhibited the virus
symptom formation (Fig. 5B–C) and the rapid death of the plants
caused by the systemic invasion by TBSV RNA (Fig. 5C). The
CPZ treatment had no visible effect on the young leaves, while the
older leaves became wavy (not shown) when CPZ was applied at
600 mM concentration.
Treatment of N. benthamiana leaves via infiltration of 1600 mM
QC 30 min prior to inoculation with TBSV virion preparation
also resulted in inhibition of TBSV RNA accumulation in the
infiltrated leaves (by 99%, Fig. 6A). The formation of virus-
induced symptoms was inhibited in QC-treated plants (Fig. 6B).
However, the protection of the whole plants from TBSV infection
was incomplete and QC-treated plants also developed the serious
symptoms caused by TBSV infection with a delay of two-to-four
days, followed by the death of the plants (not shown). Thus, the
protection caused by QC treatment against TBSV infections is
incomplete and temporary under the conditions used.
CPZ Inhibits the Accumulation of Tobacco Mosaic Virus
and Turnip Crinkle Virus in N. Benthamiana Protoplasts
To test if the effects of CPZ and QC are specific against TBSV,
we also tested if these compounds can affect the replication of the
related Turnip crinkle virus (TCV, Tombusviridae, flavivirus-super-
group) and the unrelated Tobacco mosaic virus (belonging to the
alphavirus-supergroup of viruses) in N. benthamiana protoplasts.
Figure 4. Inhibition of in vitro translation of TBSV RNA by QC.
(A) The wheat germ translation assay was programmed with artificial
capped p33 mRNA carrying a poly(A) tail in the presence of CPZ, QC
and DMSO as control. The radiolabeled p33 product was analyzed on
SDS-PAGE. Each experiment was repeated three times. DMSO sample
(0.03%) was chosen as 100%. (B) Similar in vitro translation assay was
programmed with the uncapped wt TBSV gRNA, which does not carry a
poly(A) tail.
doi:10.1371/journal.pone.0007376.g004
Figure 5. Inhibition of TBSV gRNA accumulation in N.
benthamiana plants treated with CPZ. (A) Leaves were first
infiltrated with CPZ (600 mM), followed by inoculation of the same
leaves with TBSV virion preparation. Samples for viral RNA analysis were
taken from the infiltrated leaves at 4 dpi. Northern blotting (top panel)
shows the level of TBSV gRNA and sgRNAs accumulation in individual
samples using a 39 end specific probe. The bottom panel shows the
ethidium bromide stained gel indicating the levels of rRNA and TBSV
gRNA. Each experiment was repeated three times. DMSO sample was
chosen as 100%. (B–C) The delay in symptom development due to TBSV
infections in the CPZ treated plant (shown on the left) 4 and 14 dpi
indicates the potent antiviral activity of CPZ. Comparable DMSO
treatment of plant leaves prior to inoculation with TBSV did not protect
the plants from infection.
doi:10.1371/journal.pone.0007376.g005
Virus Inhibition by Acridine
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These experiments were conducted in a similar way to those
shown for TBSV in Fig. 1. Interestingly, CPZ inhibited the
accumulation of TMV RNA by ,80% (Fig. 7A, lanes 3–4) and
that of TCV by up to 43% (Fig. 7B–C). On the contrary, QC had
only a small effect on TMV RNA accumulation (Fig. 7A, lanes 6–
10), while QC treatment reduced TCV RNA accumulation by
90% when applied prior to electroporation in N. benthamiana
protoplasts (Fig. 7B, lane 8). Direct comparison of the effect of
CPZ and QC treatment on TCV and TBSV RNA accumulation
in N. benthamiana protoplasts revealed that TBSV replication was
more sensitive to CPZ treatment than TCV replication (Fig. 7C,
compare lanes 3 and 7). Thus, while CPZ seems to have a broader
antiviral effect, QC was inhibiting specifically TBSV and TCV
RNA accumulation.
Discussion
Small molecule inhibitors of virus replication are drug
candidates to interfere with virus infections or cure viral diseases.
This area is vastly understudied for plant viruses, though inhibitors
against plant viruses might also be useful against animal viruses
due to common replication mechanisms shared by many RNA
viruses. In addition to the possible use of these compounds as
antiviral agents, they could also be useful to understand various
steps of virus replication and/or virus-host interactions.
The two acridine derivatives studied in this work for their anti-
TBSV effects are CPZ and QC with known anti-prion
[28,36,37,38,39,40], anti-Alzheimer’s beta-amyloid fibril forma-
tion [41], anti-malaria [42], anti-Bacillus anthracis toxin [43] and
anti-cancer activities [44,45]. Additional documented effects of
CPZ include inhibition of the formation of clathrin-coated pits and
the relocation of clathrin and clathrin-associated adaptor complex
AP2 from the cell surface, which is critical for clathrin-mediated
endocytosis used by severe acute respiratory syndrome coronavirus
(SARS-CoV), dengue virus 2, Crimean-Congo hemorrhagic fever
virus, vesicular stomatitis virus, HIV, mouse hepatitis virus type 2
during cell entry [46,47,48,49,50,51,52].
We have found that CPZ and QC affected TBSV replication.
Although both compounds were the most effective when applied
before or at the beginning of virus infection, detailed biochemical
analysis of the mechanism of action by CPZ and QC revealed that
they acted via different mechanisms.
In vitro RNA - protein binding experiments have shown that
QC inhibited the binding of p33 replication protein to the internal
replication element [p33RE consisting of the stem-loop RII(+)-SL]
required for recruitment of the TBSV RNA into replication
[11,13]. The reduced level of viral RNA recruitment by p33
caused by QC is expected to lead to low level of replicase
assembly, which requires the viral RNA component [14,32,53].
QC also inhibited minus-strand synthesis, but not (+)-strand
synthesis, suggesting that QC selectively interacts with the viral
(+)RNA template. Indeed, the RNA binding feature of QC has
been demonstrated before including GAAA tetraloop [54], various
base-paired RNAs [55], A-form and H(L)-form of poly(rC)-
poly(rG) [56], and single-stranded poly(A) [57]. In addition to the
above steps, QC also inhibited the translation of TBSV genomic
RNA, which is uncapped and nonpolyadenylated. This inhibition
was specific, since QC did not inhibit the translation of the
capped/polyadenylated p33 mRNA in the wheat germ assay
(Fig. 4). Altogether, although QC can inhibit various steps during
the infectious cycle of TBSV (Fig. 8), it is possible that most or all
of these inhibitory effects are due to the likely ability of QC to bind
to viral RNA and inhibit protein - RNA interactions essential for
TBSV replication.
The inhibitory effect of QC on TBSV replication is unlikely due
to a putative general cytotoxic effect, since TMV RNA replication
in protoplasts was not inhibited by QC under similar conditions
used in the TBSV studies (Fig. 7A). TMV RNA is capped, so its
translation might not be inhibited by QC. Similar to TBSV, the
replication of the related TCV was inhibited by QC efficiently,
especially when applied prior to electroporation (Fig. 7B).
The in vitro experiments have revealed that CPZ inhibits TBSV
replication using a different mechanism from that of QC. We
found that CPZ reduced drastically the in vitro activity of the
TBSV replicase at the early time points, but CPZ had only weak
inhibitory effect on binding of p33 to (+)RNA. In addition, CPZ
did not inhibit the translation of TBSV gRNA. Also, CPZ did not
inhibit (2) or (+)strand synthesis in an assay with the solubilized/
purified tombusvirus replicase (Fig. 2C–D). In vitro replication of
the TBSV repRNA was reduced only moderately by CPZ when
used at a late (60 min) time point (Fig. 2A), arguing that once most
of the replicase complexes have been assembled (between 0–
60 min), then it becomes less sensitive to the presence of CPZ.
Based on these data, it is likely that CPZ inhibits the assembly of
the TBSV replicase, which occurs after translation and template
selection/recruitment of the viral (+)RNA (Fig. 8). Albeit the
assembly process is not yet completely understood for tombus-
viruses or other (+)-strand RNA viruses, it is likely that multiple
viral protein - host protein and viral RNA - protein interactions as
well as protein - subcellular membrane interactions have to take
place for successful replicase assembly [24,58]. Although CPZ
Figure 6. Inhibition of TBSV gRNA accumulation in N.
benthamiana plants treated with QC. (A) Infiltration of leaves with
QC (1600 mM), inoculation with TBSV and analysis of RNA samples were
done as described under Fig. 5. Note that QC treatment resulted in
delay of TBSV symptom formation when compared with DMSO-treated
control plants. Note the 40% accumulation of TBSV RNA in one sample
(marked with a star), which is likely due to areas in the leaf not (or
partly) soaked by the compound during infiltration. Each experiment
was repeated three times. DMSO sample was chosen as 100%. (B) The
delay in symptom development due to TBSV infections in the QC
treated plant (shown on the left) 10 dpi indicates an antiviral activity for
QC when compared with the DMSO treatment of plant, which shows
more severe symptoms (coloring and stunting).
doi:10.1371/journal.pone.0007376.g006
Virus Inhibition by Acridine
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could affect many of the above interactions, we obtained some
evidence that interactions of the above factors with the subcellular
membranes might be affected by the CPZ treatment (Fig. 2B).
This is based on pre-treatment of the membrane fraction of the
yeast cell-free extract with CPZ, followed by thorough washing of
the membrane to remove unbound chemicals prior to the addition
of the viral RNA template, the viral replication proteins, and the
cytosolic (soluble) fraction of the cell-free extract. The pre-
treatment of the membrane fraction with CPZ has led to reduced
level of TBSV replication in vitro (Fig. 2B). Since CPZ binds
rapidly to phospholipid bilayers and disturbs the molecular
ordering of phospholipids [33] and CPZ is also known to affect
the bending of the membrane lipids by favoring outward bending
of membranes, we propose that CPZ could inhibit the assembly of
the replicase complex and thus, TBSV replication via altering the
features of intracellular membranes. Indeed, CPZ, when inserted
into lipid bilayers, has been shown to induce spontaneously
positive curvatures, and inhibit the formation of surfaces with
negative curvature [59]. However, replication and the assembly of
the replicase of some RNA viruses needs bending of the
membranes in inward direction to assemble viral-induced
spherules, where replication takes place [60,61]. So, the opposing
bending effect of CPZ and viral replication proteins during the
replicase assembly might lead to reduced efficiency of viral
Figure 7. Inhibition of the distantly related TMV RNA and the closely related TCV RNA accumulation in N. benthamiana protoplasts
by treatment with CPZ or QC. (A) Northern blot analysis with a 39 end specific probe was used to detect the accumulation levels of TMV gRNA. N.
benthamiana protoplasts were treated with the shown concentrations of CPZ and QC either before or after electroporation. See further details in the
legend to Fig. 1. Note that the % of TMV RNA accumulation was normalized based on rRNA levels in the same samples to correct for sample-to-
sample variation. DMSO concentrations were the following: 0.03%, lanes 3, 6, 11; 0.04%, lanes 4, 7, 12; 0.06%, lanes 5, 8, 9, 13, 14; and 0.08% in lanes
10 and 15. (B) Ethidium-bromide stained agarose gel electrophoretic analysis of the accumulation levels of TCV gRNA. N. benthamiana protoplasts
were treated with the shown concentrations of CPZ and QC either before or after electroporation. See further details in the legend to Fig. 1. DMSO
concentrations were the following: 0.005%, lanes 1, 4; 0.01%, lanes 2, 3, 5, 6; 0.02%, lanes 7, 10; and 0.06% in lanes 8, 9 and 11. (C) Comparison of the
inhibitory effect of CPZ on TCV versus TBSV RNA accumulation. Ethidium-bromide stained agarose gel electrophoretic analysis of the accumulation
levels of TCV and TBSV gRNAs from the same N. benthamiana protoplasts preparations. The protoplasts were treated with the shown concentrations
of CPZ 30 min after electroporation. See further details in the legend to Fig. 1. DMSO concentrations were the following: 0.02%, lanes 2, 4, 6, 8; 0.04%,
lanes 3, 5, 7 and 9.
doi:10.1371/journal.pone.0007376.g007
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replicase assembly. However, we cannot rule out that CPZ could
bind to some membrane proteins present in the membrane
fraction of the cell extract, which could also lead to a decrease in
viral replicase assembly.
Therefore, the respective effects of QC and CPZ against plant
viruses parallel their putative mode of action on prion propaga-
tion. Indeed, antiprion activity of both QC and CPZ may be
related to their ability to down regulate the protein folding activity
of the ribosome (Ribosome-borne Protein Folding Activity or
RPFA) [62,63]. Interestingly, QC is able to directly interact with
Domain V of the large rRNA (which bears the RPFA that may be
involved in prion propagation) whereas the effect of CPZ would be
Figure 8. The proposed inhibitory effects of CPZ and QC treatments on various steps of TBSV RNA replication. Five early steps of TBSV
replication [24,70] are shown schematically, including translation of the viral RNA, template selection, viral RNA/protein recruitment into replication,
assembly of the viral replicase complex and viral RNA synthesis. While the inhibitory effect of QC has been indicated in several steps, CPZ has been
shown to affect mostly one step. The viral cis-acting RNA structures, such as p33RE (p33 recognition element), RSE (replication silencer element) and
gPR (genomic promoter), which are likely bound by QC, are magnified.
doi:10.1371/journal.pone.0007376.g008
Virus Inhibition by Acridine
PLoS ONE | www.plosone.org 8 October 2009 | Volume 4 | Issue 10 | e7376
more indirect and involves its ability to interact with and disturb
cell membranes thus activating a transduction pathway ultimately
leading to down regulation of the synthesis of rRNA and also of
other ribosome constituents (MB, unpublished). The parallelism
with the situation observed here (QC having a role through a
direct interaction with RNA, CPZ having a more indirect role
involving its capacity to interfere with cell membrane) is
particularly noticeable. The analysis of the effect on plant viruses
of other antiprion compounds also able to interfere with RPFA
and RNA is therefore of interest and will be the subject of future
studies.
The effect of CPZ on cellular membranes can also explain why
the treatment with CPZ is so effective in whole plant experiments
as well as against the related TCV and the distantly related TMV,
which also requires subcellular membrane for its replication [64].
Moreover, CPZ has been shown to inhibit the assembly of
enveloped viruses [65,66], which also require membrane bending.
In contrast, the effect of QC seems to be narrower and includes
plant viruses without cap and poly(A) ends, such as TBSV and
TCV, members of Tombusviridae, a large family of plant viruses.
Materials and Methods
Chemicals
Chlorpromazine (CPZ) and quinacrine (QC) were purchased
from Sigma. Both compounds were dissolved in DMSO and
stored at 220uC as a stock at concentration of 100 mM. Further
dilutions were made with water just before use.
Preparation and Electroporation of N. Benthamiana
Protoplasts
For protoplast isolation, N. benthamiana callus culture was treated
with 1 g cellulysin and 0.2 g macerase (Calbiochem) as described
[17]. Freshly prepared protoplasts were electroporated with 2 mg
T7 RNA polymerase transcribed TBSV, TMV or TCV genomic
RNAs as described [17,25]. CPZ and QC dissolved in DMSO
were added at various concentrations as shown in the figures to
protoplasts 30 min before or 1 hour after electroporation of the
viral RNAs. In the control samples, DMSO was added to the
protoplasts at similar concentrations to that present in CPZ or QC
preparations. Incubation of protoplasts was done in the dark at
room temperature.
Analysis of TBSV, TMV and TCV RNA Accumulation in N.
Benthamiana Protoplasts
Total RNA was extracted 40 hrs after electroporation, followed
by agarose gel analysis and Northern blotting using radiolabeled
TBSV probe as described [17]. The template for the TMV RNA
probe was generated by PCR using the full-length cDNA for TMV
and primers #2890 (59-TCTGGTTTGGTTTGGACCTC-39)
and #2889 (59-GTAATACGACTCACTATAGGGATTC-
GAACCC-39). The normalization of samples was done based on
quantified ribosomal RNA levels in total RNA samples visualized
by ethidium-bromide staining of gels.
In Vitro TBSV Replication Assay Based on Yeast Cell-Free
Extract
Cell-free yeast extract was prepared and replication assay for
TBSV DI-72 RNA was performed as described [23]. For the
treatment of the membrane fraction of the yeast cell-free extract,
first, we separated the membrane fraction from the soluble fraction
by centrifuging 20 ml of yeast extract at 21,000 g for 10 min at
4uC. Second, the membrane fraction was treated for 15 min at
25uC with CPZ or QC at the final concentration of 50 mM and
20 mM, respectively. To remove the unbound excess compounds
from the membrane fraction, we washed the membrane fraction
twice with 100 ml buffer A (30 mM HEPES-KOH, pH 7.4,
100 mM potassium acetate, and 2 mM magnesium acetate). After
the wash step, we performed the TBSV replication assay for
3 hours at 25uC using the above membrane fraction in
combination with the untreated soluble fraction according to [23].
In Vitro Tombusvirus Replicase Assay for Minus- and Plus-
Strand Synthesis in the Presence of CPZ and QC
For the preparation of the tombusvirus replicase, we used N.
benthamiana plants infected with Cucumber necrosis virus, a close
relative of TBSV, which can replicate TBSV RNA templates as
efficiently as the TBSV replicase [34]. After preparing the
membrane fraction containing the active CNV replicase, we
solubilized the replicase and partially purified it as described [34].
The obtained tombusvirus replicase is template dependent and it
can use added TBSV-derived RNA templates for complementary
RNA synthesis, including (+) or (2)RNA synthesis depending on
the polarity of the added RNA template [34,35,67]. We performed
the replicase assay for 3 hours at 25uC using (+) or (2)DI-72 RNA
in the presence of 50 mM CPZ, 20 mMQC or DMSO (0.01% and
0.004%, respectively) as a control. The RNA products obtained
were analyzed by denaturing 8 M urea PAGE as described
[34,35,67].
In Vitro Assay for Testing the Binding of p33 Replication
Protein to the Viral RNA in the Presence of CPZ and QC
The sequence for RII(+)-SL RNA (containing the cis-acting
p33RE that is involved in selective binding to p33) was amplified
with PCR using primers #1300 ( 59- GTAATACGACTCACTA-
TAGAGGTTTGTGAGAAGGTTGG- 39) and #1301 (59-
CTGGCTCGTGTGTAAGTACG-39) and DI-72 cDNA clone
as a template [68]. Radioactively labeled RII(+)-SL RNA was
obtained using T7 polymerase transcription as described [13].
MBP tagged p33C [13] and MBP, as a control, were affinity
purified from E. coli [69]. The recombinant proteins were used in
1, 0.2, 0.4, and 0.1 mg for incubation with 1 ng of radioactively
labeled RII(+)-SL RNA [13] in a binding buffer [12 mM HEPES
pH 7.9, 15 mM KCl, 0.2 mM DTT, 10% glycerol, 2 U of RNase
inhibitor (Ambion)] [13,69] in the presence or absence of 50 mM
of CPZ, 20 mM of QC or DMSO (0.01% and 0.004%,
respectively) at 25uC for 15 min. Samples were analyzed by 5%
non-denaturing polyacrylamide gel electrophoresis at 4uC ran at
200 V.
Wheat Germ Cell Free Extract-Based in Vitro Translation
of TBSV RNA
Uncapped, nonpolyadenylated TBSV genomic RNA transcripts
were obtained with the T7 transcription using linearized DNA
template [68]. Capped and polyadenylated p33 mRNA was
obtained with the T7 transcription using PCR template made with
primers # 2144 (59-GTAATACGACTCACTATAGGG AAGC-
TATACCAAGCATACAATC-39) and #2145 (59-TTTTTTT-
TT-TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT-
AAAACCTAAGAGTCAC-39). In vitro translation of RNA
transcripts was carried out in a wheat germ extract (Promega)
according to manufacturer’s recommendation. Briefly, 0.3 pmol of
RNA transcripts, 3 ml wheat germ extract and 0.3 ml amino acid
mix without methionine (provided by the manufacturer) were
mixed in 50 mM potassium acetate with a final volume of 6 ml. In
addition, 1 ml of CPZ (final concentration of 30 mM or 50 mM),
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QC (10 or 20 mM), and DMSO (0.05%) was also added. Reactions
were conducted for 1 hour in the presence of [35S] methionine
(1000 Ci/mmol) at room temperature. In vitro translation was
stopped by denaturation at 100uC for 3 minutes. Products were
analyzed using 10% SDS-PAGE and quantified by Typhoon 9400
and ImageQuant (GE Healthcare).
RNA Analysis of TBSV Accumulation in N. Benthamiana
Plants Treated with CPZ or QC
Two leaves of N. benthamiana plants (four leaf-stage) were
infiltrated with 2 ml of a 600 mM solution of CPZ or of a 1600 mM
solution of QC. Control plants were infiltrated with the same
percentage of DMSO that was present in the CPZ and QC
solutions. The infiltrated leaves were inoculated with a purified
TBSV virion preparation 30 min after infiltration. Total RNA was
extracted 4 days post inoculation (dpi) and 1% agarose gel
electrophoresis was done to analyze viral and ribosomal RNAs.
Northern blot analysis was performed with a TBSV specific probe
as described above for the protoplast experiments.
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